These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 12915238

  • 1. Ultra-long antagonism of kappa opioid agonist-induced diuresis by intracisternal nor-binaltorphimine in monkeys.
    Ko MC, Willmont KJ, Lee H, Flory GS, Woods JH.
    Brain Res; 2003 Aug 22; 982(1):38-44. PubMed ID: 12915238
    [Abstract] [Full Text] [Related]

  • 2. Intracisternal nor-binaltorphimine distinguishes central and peripheral kappa-opioid antinociception in rhesus monkeys.
    Ko MC, Johnson MD, Butelman ER, Willmont KJ, Mosberg HI, Woods JH.
    J Pharmacol Exp Ther; 1999 Dec 22; 291(3):1113-20. PubMed ID: 10565831
    [Abstract] [Full Text] [Related]

  • 3. Activation of kappa-opioid receptors inhibits pruritus evoked by subcutaneous or intrathecal administration of morphine in monkeys.
    Ko MC, Lee H, Song MS, Sobczyk-Kojiro K, Mosberg HI, Kishioka S, Woods JH, Naughton NN.
    J Pharmacol Exp Ther; 2003 Apr 22; 305(1):173-9. PubMed ID: 12649366
    [Abstract] [Full Text] [Related]

  • 4. Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates.
    Ko MC, Husbands SM.
    J Pharmacol Exp Ther; 2009 Jan 22; 328(1):193-200. PubMed ID: 18842704
    [Abstract] [Full Text] [Related]

  • 5. Lack of evidence of kappa2-selective activation of G-proteins: kappa opioid receptor stimulation of [35S] GTPgammaS binding in guinea pig brain.
    Childers SR, Xiao R, Vogt L, Sim LJ.
    Biochem Pharmacol; 1998 Jul 01; 56(1):113-20. PubMed ID: 9698095
    [Abstract] [Full Text] [Related]

  • 6. Opioid antagonist profile of SC nor-binaltorphimine in the formalin paw assay.
    Wettstein JG, Grouhel A.
    Pharmacol Biochem Behav; 1996 Feb 01; 53(2):411-6. PubMed ID: 8808151
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Activation of peripheral kappa opioid receptors inhibits capsaicin-induced thermal nociception in rhesus monkeys.
    Ko MC, Butelman ER, Woods JH.
    J Pharmacol Exp Ther; 1999 Apr 01; 289(1):378-85. PubMed ID: 10087027
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Kappa-opioid receptor agonist protects the microcirculation of skeletal muscle from ischemia reperfusion injury.
    Lin JY, Hung LM, Lai LY, Wei FC.
    Ann Plast Surg; 2008 Sep 01; 61(3):330-6. PubMed ID: 18724138
    [Abstract] [Full Text] [Related]

  • 16. Nor-binaltorphimine: a potent and selective kappa-opioid receptor antagonist with long-lasting activity in vivo.
    Endoh T, Matsuura H, Tanaka C, Nagase H.
    Arch Int Pharmacodyn Ther; 1992 Sep 01; 316():30-42. PubMed ID: 1326932
    [Abstract] [Full Text] [Related]

  • 17. Physical presence of nor-binaltorphimine in mouse brain over 21 days after a single administration corresponds to its long-lasting antagonistic effect on κ-opioid receptors.
    Patkar KA, Wu J, Ganno ML, Singh HD, Ross NC, Rasakham K, Toll L, McLaughlin JP.
    J Pharmacol Exp Ther; 2013 Sep 01; 346(3):545-54. PubMed ID: 23853171
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Central kappa opioid receptor-evoked changes in renal function in conscious rats: participation of renal nerves.
    Kapusta DR, Obih JC.
    J Pharmacol Exp Ther; 1993 Oct 01; 267(1):197-204. PubMed ID: 8229746
    [Abstract] [Full Text] [Related]

  • 20. Differential cardiovascular and renal responses produced by microinjection of the {kappa}-opioid U-50488H [(trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]-benzene-acetamide) methane sulfonate] into subregions of the paraventricular nucleus.
    Gottlieb HB, Varner KJ, Kenigs VA, Cabral AM, Kapusta DR.
    J Pharmacol Exp Ther; 2005 Feb 01; 312(2):678-85. PubMed ID: 15381735
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.